MBX Biosciences Common Net Income
| MBX Stock | 32.96 0.41 1.26% |
As of the 2nd of March, MBX Biosciences secures the downside deviation of 4.91, and Mean Deviation of 4.46. In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of MBX Biosciences Common, as well as the relationship between them.
MBX Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing MBX Biosciences' valuation are provided below:We have found one hundred eight available fundamental ratios for MBX Biosciences, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of MBX Biosciences last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself next year. Enterprise Value is likely to rise to about 740.3 M in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -55.7 M | -58.5 M | |
| Net Loss | -55.7 M | -58.5 M | |
| Net Loss | (2.13) | (2.24) |
MBX | Net Income | Build AI portfolio with MBX Stock |
The evolution of Net Income for MBX Biosciences Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how MBX Biosciences compares to historical norms and industry peers.
Latest MBX Biosciences' Net Income Growth Pattern
Below is the plot of the Net Income of MBX Biosciences Common over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in MBX Biosciences Common financial statement analysis. It represents the amount of money remaining after all of MBX Biosciences Common operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is MBX Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MBX Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (61.92 M) | 10 Years Trend |
|
Net Income |
| Timeline |
MBX Net Income Regression Statistics
| Arithmetic Mean | (32,263,888) | |
| Coefficient Of Variation | (39.57) | |
| Mean Deviation | 9,373,593 | |
| Median | (26,135,000) | |
| Standard Deviation | 12,766,786 | |
| Sample Variance | 163T | |
| Range | 35.8M | |
| R-Value | (0.69) | |
| Mean Square Error | 90.8T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | (1,747,735) | |
| Total Sum of Squares | 2607.9T |
MBX Net Income History
Other Fundumenentals of MBX Biosciences Common
MBX Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for MBX Biosciences is extremely important. It helps to project a fair market value of MBX Stock properly, considering its historical fundamentals such as Net Income. Since MBX Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MBX Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MBX Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MBX Biosciences. Expected growth trajectory for MBX significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MBX Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
MBX Biosciences Common's market price often diverges from its book value, the accounting figure shown on MBX's balance sheet. Smart investors calculate MBX Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since MBX Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that MBX Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MBX Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, MBX Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MBX Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MBX Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MBX Biosciences.
| 12/02/2025 |
| 03/02/2026 |
If you would invest 0.00 in MBX Biosciences on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding MBX Biosciences Common or generate 0.0% return on investment in MBX Biosciences over 90 days. MBX Biosciences is related to or competes with Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. MBX Biosciences is entity of United States More
MBX Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MBX Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MBX Biosciences Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.91 | |||
| Information Ratio | 0.0601 | |||
| Maximum Drawdown | 29.11 | |||
| Value At Risk | (7.57) | |||
| Potential Upside | 14.4 |
MBX Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MBX Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MBX Biosciences' standard deviation. In reality, there are many statistical measures that can use MBX Biosciences historical prices to predict the future MBX Biosciences' volatility.| Risk Adjusted Performance | 0.0661 | |||
| Jensen Alpha | 0.4333 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.0742 | |||
| Treynor Ratio | 3.3 |
MBX Biosciences March 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0661 | |||
| Market Risk Adjusted Performance | 3.31 | |||
| Mean Deviation | 4.46 | |||
| Semi Deviation | 4.58 | |||
| Downside Deviation | 4.91 | |||
| Coefficient Of Variation | 1334.34 | |||
| Standard Deviation | 6.06 | |||
| Variance | 36.7 | |||
| Information Ratio | 0.0601 | |||
| Jensen Alpha | 0.4333 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.0742 | |||
| Treynor Ratio | 3.3 | |||
| Maximum Drawdown | 29.11 | |||
| Value At Risk | (7.57) | |||
| Potential Upside | 14.4 | |||
| Downside Variance | 24.06 | |||
| Semi Variance | 21.0 | |||
| Expected Short fall | (5.18) | |||
| Skewness | 0.8619 | |||
| Kurtosis | 1.08 |
MBX Biosciences Common Backtested Returns
At this stage we consider MBX Stock to be not too volatile. MBX Biosciences Common has Sharpe Ratio of 0.0228, which conveys that the company had a 0.0228 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for MBX Biosciences, which you can use to evaluate the volatility of the entity. Please verify MBX Biosciences' mean deviation of 4.46, and Downside Deviation of 4.91 to check out if the risk estimate we provide is consistent with the expected return of 0.13%. MBX Biosciences has a performance score of 1 on a scale of 0 to 100. The firm secures a Beta (Market Risk) of 0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MBX Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding MBX Biosciences is expected to be smaller as well. MBX Biosciences Common currently secures a risk of 5.85%. Please verify MBX Biosciences Common semi variance, as well as the relationship between the daily balance of power and price action indicator , to decide if MBX Biosciences Common will be following its current price movements.
Auto-correlation | -0.39 |
Poor reverse predictability
MBX Biosciences Common has poor reverse predictability. Overlapping area represents the amount of predictability between MBX Biosciences time series from 2nd of December 2025 to 16th of January 2026 and 16th of January 2026 to 2nd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MBX Biosciences Common price movement. The serial correlation of -0.39 indicates that just about 39.0% of current MBX Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 6.27 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
MBX Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, MBX Biosciences Common reported net income of (61.92 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
MBX Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MBX Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MBX Biosciences could also be used in its relative valuation, which is a method of valuing MBX Biosciences by comparing valuation metrics of similar companies.MBX Biosciences is currently under evaluation in net income category among its peers.
MBX Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MBX Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MBX Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
MBX Fundamentals
| Return On Equity | -0.24 | ||||
| Return On Asset | -0.17 | ||||
| Current Valuation | 1.07 B | ||||
| Shares Outstanding | 44.9 M | ||||
| Shares Owned By Insiders | 2.83 % | ||||
| Shares Owned By Institutions | 97.17 % | ||||
| Number Of Shares Shorted | 2.2 M | ||||
| Price To Book | 3.77 X | ||||
| EBITDA | (67.95 M) | ||||
| Net Income | (61.92 M) | ||||
| Total Debt | 171 K | ||||
| Book Value Per Share | 8.67 X | ||||
| Cash Flow From Operations | (54.68 M) | ||||
| Short Ratio | 2.97 X | ||||
| Earnings Per Share | 7.67 X | ||||
| Target Price | 61.1 | ||||
| Number Of Employees | 43 | ||||
| Market Capitalization | 1.46 B | ||||
| Total Asset | 268.54 M | ||||
| Retained Earnings | (137.5 M) | ||||
| Working Capital | 256.24 M | ||||
| Net Asset | 268.54 M |
About MBX Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MBX Biosciences Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MBX Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MBX Biosciences Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MBX Stock Analysis
When running MBX Biosciences' price analysis, check to measure MBX Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences is operating at the current time. Most of MBX Biosciences' value examination focuses on studying past and present price action to predict the probability of MBX Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences' price. Additionally, you may evaluate how the addition of MBX Biosciences to your portfolios can decrease your overall portfolio volatility.